Quarterly report pursuant to Section 13 or 15(d)

Net (Loss) Income Per Share (Tables)

Net (Loss) Income Per Share (Tables)

9 Months Ended

Sep. 30, 2022

Schedule of the Computation of Basic and Diluted Net Loss Per Share of Common Stock

The following tables set forth the computation of basic and diluted net (loss) income per share of common stock for the three and nine months ended September 30, 2022 and three months ended September 30, 2021, and common stock and preferred stock for the nine months ended September 30, 2021 (in thousands, except share and per share amounts):


	Three Months Ended
	September 30, 2022
	Common stock

Basic income per share:
Net income	$	3,192
Weighted average shares	9,413,466
Basic net income per share	$	0.34

Diluted income per share:
Net income	$	3,192
Weighted average shares - basic	9,413,466
Effect of dilutive securities:

Potentially dilutive shares	166
Weighted average shares - diluted	9,413,632
Diluted net income per share	$	0.34


	Nine Months Ended
	September 30, 2022
	Common stock


Net loss	$	(31,846)

Weighted average shares	9,404,679
Basic and diluted net loss per share	$	(3.39)


	Three Months Ended
	September 30, 2021
	Common stock
	Continuing Operations		Discontinued Operations

Allocation of undistributed net (loss) income	$	(17,471)	$	76

Weighted average shares	8,374,200		8,374,200
Basic and diluted net (loss) income per share	$	(2.09)	$	0.01


	Nine Months Ended
	September 30, 2021
	Common stock				Preferred stock
	Continuing Operations		Discontinued Operations		Continuing Operations		Discontinued Operations

Allocation of undistributed net (loss) income	$	(63,602)	$	37	$	(1,616)	$	1

Weighted average shares	7,927,152		7,927,152		483,517		483,517
Basic and diluted net (loss) income per share	$	(8.02)	$	0.00	$	(3.34)	$	0.00

Schedule of Anti-dilutive Securities Excluded From Computation of Diluted Weighted Shares Outstanding

The following outstanding securities have been excluded from the computation of diluted weighted shares outstanding for the three and nine months ended September 30, 2022 and 2021, as they could have been anti-dilutive:


	Three and Nine Months Ended
	September 30,
	2022	2021
Stock options	1,260,906	1,122,785
Warrants on common stock1	366,990	367,186
Restricted Stock Units	—	6,493

1 The weighted average number of common shares outstanding as of September 30, 2021 included the weighted average effect of the 139,747 pre-funded warrants issued in connection with the underwritten public offering that closed in January 2021 because the exercise of such warrants requires only nominal consideration ($0.012 per share exercise price for each pre-funded warrant). During 2021, the holder exercised 25,740 of the pre-funded warrants. As of September 30, 2022, the weighted average number of common shares outstanding included the weighted average effect of the remaining 114,007 pre-funded warrants outstanding. These pre-funded warrants are not included in the table above.